Questionnaire results
A questionnaire administered
among HIV core hospitals across Japan in 2022
Japan Agency for Medical Research and Development, Research Program on HIV/AIDS
The study group on “A study on the management of opportunistic infections associated with early and prolonged use of ART”
Principal investigator: Katsuji Teruya
- Trends in Opportunistic Complications and Malignancies Associated with Human Immunodeficiency Virus (HIV) Infection in Japan: Analyses of 2022 Data
- Trends of incidence of malignancies (non-acquired immunodeficiency syndrome [AIDS]-defining malignancies) among patients infected with human immunodeficiency virus (HIV)
(2.6 MB)